Please read the information below and click the Register button to access the Management of Group A, β-Hemolytic Streptococcal Pharyngotonsillitis in Children CME supplement evaluation and posttest. Please complete the evaluation and post-test to receive your certificate of participation instantly.  A minimum score of 70% on the posttest is required for certification. If you do not pass the test, you will be given one more opportunity to retake the test.

RELEASE DATE: December 2006
EXPIRATION DATE: December 31, 2007

Please click here to download a pdf of the supplement.

There is no fee to participate in this activity.  If you have any questions regarding this program, please contact us at helpdesk@ScepterCME.com

This activity has been prepared under the direction of:
Co-Authors
Itzhak Brook, MD
Professor of Pediatrics
Georgetown University School of Medicine
Washington, DC

Joseph E. Dohar, MD
Associate Professor of Otolaryngology
University of Pittsburgh School of Medicine
Clinical Director of the Voice, Resonance, and Swallowing Center
Research Director of the Airway Center
Co-Director of the Wound Healing Program
Children’s Hospital of Pittsburgh
Pittsburgh, Pennsylvania

Educational Objectives

• Apply appropriate antibiotic therapy for the treatment of acute pharyngotonsillitis, according to current recommendations of the Infectious Diseases Society of America (IDSA) and the American Academy of Pediatrics (AAP)
  
• In order to improve outcomes for your patients, evaluate the incidence of treatment failure with penicillin V in acute GABHS pharyngotonsillitis and choose appropriate treatment options
  
• Given the high incidence of recurrence after penicillin treatment, determine potential reasons for treatment failure in order to reduce recurrences and improve outcomes
  
• Evaluate cross-reactivity between penicillins and cephalosporins in patients with a history of penicillin allergy, in order to determine appropriate medication management
  
• Compare the efficacy of penicillins and cephalosporins in GABHS pharyngotonsillitis according to current recommendations of the IDSA
  
• Evaluate options for improving compliance of antibiotic therapy in GABHS pharyngotonsillitis, particularly in your pediatric population

Target Audience
This supplement is intended for family physicians, clinical pediatricians, primary care physicians, and other health care professionals interested in the care of children with pharyngotonsillitis.

Accreditation Statement
Scepter™ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement
Scepter™ designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Disclosure, and Disclosure Information
Scepter™ adheres to the ACCME Essential Areas and policies, including the Standards for Commercial Support, regarding industry support of continuing medical education. Disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, will be disclosed to learners.

Disclaimer
The faculty, Scepter™, and Abbott do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information of each product for approved indications, contraindications, and warnings.